Intravitreal Ranibizumab for Choroidal Neovascularization in Best's Vitelliform Macular Dystrophy in a 6-Year-Old Boy

J Pediatr Ophthalmol Strabismus. 2011 Mar 15:48 Online:e19-22. doi: 10.3928/01913913-20110308-02.

Abstract

A 6-year-old boy with a family history of Best's vitelliform macular dystrophy presented with a unilateral choroidal neovascularization. He responded well to a single injection of intravitreal ranibizumab. His visual acuity improved from 6/18 to 6/9 in the affected eye. His condition remained stable for 1½ years after treatment.